Pfizer Inc. (NEO:PFE)

Canada flag Canada · Delayed Price · Currency is CAD
11.31
-0.10 (-0.88%)
Apr 3, 2025, 1:53 PM EST
-13.07%
Market Cap 200.50B
Revenue (ttm) 91.55B
Net Income (ttm) 11.56B
Shares Out n/a
EPS (ttm) 2.03
PE Ratio 17.35
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 60,851
Average Volume 66,866
Open 11.41
Previous Close 11.41
Day's Range 11.26 - 11.46
52-Week Range 11.24 - 14.73
Beta 0.54
RSI 35.40
Earnings Date Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Cboe Canada
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.